Kanazawa, Japan

Mizuho Nakayama

This inventor holds 1 USPTO granted patent. Top assignee: Kanazawa University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mizuho Nakayama. Retrieved from https://idiyas.com/inventor/mizuho-nakayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mizuho Nakayama: Innovator in Organoid Research

Introduction

Mizuho Nakayama is a prominent inventor based in Kanazawa, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of organoids with metastatic properties. His work is crucial for advancing our understanding of cancer biology and potential therapeutic approaches.

Latest Patents

Mizuho Nakayama holds a patent for an "Organoid with metastatic property and use thereof." This innovative patent describes an organoid that exhibits metastatic properties when transplanted into an immunocompetent non-human animal of the same species. The patent also includes a cell strain with similar properties and outlines the implications for research and treatment.

Career Highlights

Nakayama is affiliated with Kanazawa University, where he conducts his research. His work has garnered attention for its potential applications in cancer treatment and understanding tumor behavior. His dedication to advancing scientific knowledge is evident in his innovative research.

Collaborations

Mizuho Nakayama collaborates with esteemed colleagues, including Masanobu Oshima and Eri Sakai. Their combined expertise enhances the research efforts and contributes to the development of groundbreaking solutions in the field.

Conclusion

Mizuho Nakayama's contributions to organoid research represent a significant advancement in cancer biology. His innovative patent and collaborative efforts highlight the importance of research in developing effective treatments. The impact of his work will likely resonate in the scientific community for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…